Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with 2-aminopurine.
Porcine reproductive and respiratory syndrome virus (PRRSV) belongs to a group of RNA viruses that establish persistent infections. A proposed strategy for evading immunity during persistent PRRSV infection is by preventing the induction of IFN activity in pigs and/or by blocking the activation of antiviral proteins in permissive cells. IFN-gamma mRNA expression was observed in the lymph nodes and lungs of pigs infected with wild-type PRRSV strain SDSU-23983. Pretreatment of MARC-145 cells with IFN-gamma inhibited wild-type (SDSU-23983 P6) and culture-adapted (SDSU-23983 P136) PRRS viruses in a dose-dependent manner and at relatively low concentrations. The effect of IFN-gamma on virus replication included reductions in the number of infected cells, virus yield, and RNA content in single cells. Virus replication was partially restored by the addition of 2-aminopurine (2-AP), an inhibitor of dsRNA inducible protein kinase (PKR). The addition of 2-AP also restored the viral RNA content per cell to near normal levels, suggesting that inhibition of viral RNA synthesis was through PKR. The principal difference between P6 and P136 isolates was the recovery of P136 replication with lower concentrations of 2-AP. Immunostaining with anti-PKR antibody showed a redistribution of PKR from the cytoplasm into nucleoli of infected cells.
Rowland
R R
RR
Department of Biology-Microbiology, South Dakota State University, Brookings, South Dakota, USA.
Robinson
B
B
Stefanick
J
J
Kim
T S
TS
Guanghua
L
L
Lawson
S R
SR
Benfield
D A
DA
D015075:2-Aminopurine / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D000998:Antiviral Agents / Q000494:pharmacology*; D015152:Blotting, Northern; D002460:Cell Line; D002467:Cell Nucleus / Q000737:chemistry / Q000821:virology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005453:Fluorescence; D007371:Interferon-gamma / Q000235:genetics / Q000494:pharmacology*; D008168:Lung / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology; D019318:Porcine Reproductive and Respiratory Syndrome / Q000276:immunology / Q000821:virology*; D019316:Porcine respiratory and reproductive syndrome virus / Q000187:drug effects* / Q000302:isolation & purification / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013552:Swine; D013553:Swine Diseases / Q000276:immunology / Q000821:virology*; D014779:Virus Replication / Q000187:drug effects; D019892:eIF-2 Kinase / Q000032:analysis / Q000037:antagonists & inhibitors
D000998:Antiviral Agents; D012333:RNA, Messenger; D015075:2-Aminopurine; D007371:Interferon-gamma; D019892:eIF-2 Kinase